23RD IFCC-EFLM EUropean Congress of Clinical Chemistry and Laboratory Medicine National Congress of the Spanish Society of Laboratory Medicine ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
www.euromedlab2019barcelona.org
23RD IFCC-EFLM EUropean Congress of Clinical Chemistry and Laboratory Medicine
National Congress of the Spanish Society of Laboratory Medicine
FINAL programME
EUROMEDLAB app contents
Invitations 2
Committees 7
Executive Boards 9
Using the EUROMEDLAB App you can display the following: Bursaries & Awards 10
• Scientific programme with speakers’ presentations
Week Agenda 13
• Posters
• General information Opening Ceremony Programme 16
• Sponsors and exhibitors
Scientific Programme 17
• Push notifications with the latest news
• Breaking news Closed Meetings 52
Speakers & Chairs 55
Sponsored by
Congress Secretariat & Hotel Information 59
General Information 60
Registration Information 61
List of Sponsors 64
List of Exhibitors 73
Exhibition Map 92
CCIB Map 94
IFCC PRESIDENT INVITATION SEQC PRESIDENT INVITATION
Professor Howard Morris Dr. Imma Caballé
President IFCC President Congress and Spanish Society of Laboratory Medicine
Dear Friends and Colleagues, on choosing to attend EuroMedlab 2019, organised by your Dear colleagues and friends, young colleagues. The Spanish Society of Laboratory Medicine
peers and your professional societies to provide education is also very proud of the organisation of the Opening Lecture,
It is my great pleasure to welcome you to the 23rd European addressing the issues you face in daily practice. We urge you to On behalf of the Spanish Society of Laboratory Medicine 1 Plenary Lecture, 4 SEQCML Symposia, 1 Viewpoint Session
Congress of Laboratory Medicine - EuroMedlab Barcelona reject the predatory conferences organised by private companies (SEQCML) it is my great pleasure to welcome you to and 3 Satellite Meetings.
2019. The International Federation of Clinical Chemistry and marketed to cause confusion and division within our profession. EuroMedLab Barcelona 2019, the 23rd IFCC-EFLM European EuromedLab Barcelona 2019 is a unique opportunity to
Laboratory Medicine is proud to join with European Federation In particular, we ask you to be vigilant regarding invitations to join Congress of Clinical Chemistry and Laboratory Medicine in exchange academic knowledge and visit one of Europe’s largest
of Laboratory Medicine and the Spanish Society of Laboratory scientific or advisory committees; ensure you are volunteering Barcelona International Convention Centre (CCIB). commercial exhibitions of in-vitro diagnostic products.
Medicine in organising this important event for laboratory your expertise and time in a way that is contributing to our
medicine in this beautiful city with its historic cultural links and its profession. We need to be vigilant about accepting invitations to EuromedLab Barcelona 2019 is the most important European The Congress venue, the Barcelona International Convention
unique architectural style. speak at conferences and the conferences that we attend. event in laboratory medicine and it will be an opportunity to show Centre (CCIB) in Diagonal Mar is very well connected to the city
the active participation of the Spanish Society of Laboratory centre by public transport.
The provision of quality healthcare is a key element for every I am very pleased to welcome our corporate members who play Medicine founded 40 years ago, which currently has 2700
community and nation and the practice of high quality laboratory a key role bringing us the latest technologies and collaborating members, 34 commissions/ committees/ working Groups and Barcelona is a lively, modern, cosmopolitan, Mediterranean and
medicine is a major contributor to the provision of optimal to ensure quality clinical laboratory practice. This congress is 40 representatives in International Federations (IFCC/EFLM/ friendly city. Barcelona its own way of life makes it unique and
healthcare. It is necessary that clinical laboratory specialists an excellent opportunity for establish necessary networks to FESTEM/CLSI/ICSH). Our society organises five Annual allows you to experience its history and culture.
come together regularly to discuss, debate and decide on the develop your potential to its fullest in this rewarding profession. Educational Programmes with more than 2000 participants and
optimal clinical laboratory practices to support healthcare. I an extensive national (Quality assurance) EQAS programme We are sure that both the scientific and the cultural programmes
congratulate the Scientific Programme Committee for assembling I wish all delegates an enjoyable and productive congress in this distributed among 700 participating centres with 5000 registrants. will provide a wonderful opportunity to learn and hear from
such a comprehensive programme and high quality speakers to historic and significant region of the world, experts, to share your knowledge, to develop and strengthen
inform our profession and lead the discussion. EuroMedLab Barcelona 2019 is offering a few days of intense relationships with peers and to take home enjoyable and
Yours sincerely, activity with a stimulating scientific programme including plenary valuable memories.
We recognise that delegates have a wide choice of scientific Professor Howard Morris, lectures, symposia, educational workshops and poster sessions. We sincerely hope that you enjoy EuromedLab Barcelona 2019.
meetings with limited time and resources. We congratulate you President IFCC Plenary lectures and symposia will deal with the most relevant
issues in Laboratory Medicine presented by outstanding With warmest regards,
international speakers. EuroMedLab Barcelona 2019 has Dr. Imma Caballé
received a record number of 1544 abstracts, many of those from President Congress and Spanish Society of Laboratory Medicine
2 3
EFLM PRESIDENT INVITATION
Professor Neumaier Dr. Imma Caballé
EFLM President
President SEQCML
Howard
Howard Morris
Morris
Dear Colleagues and Friends, Laboratory Medicine as we know it will undergo profound changes
in the coming years due to the developments that digitalization
EUROMEDLAB, the IFCC-EFLM European Conference for will introduce into health, health care and modern medicine.
Clinical Chemistry and Laboratory Medicine is near now. New analytical technologies, extended data processing and Dr. Imma Caballé
2019 sees the 23rd edition of this major conference, this time advanced means of integration and interpretation of laboratory Morris
to held in Barcelona, Spain from the 19th to 23rd of May. The findings will greatly influence the way we – as diagnostic
EUROMEDLAB format has been immensely successful in the laboratory - participate in the future medical dialogue. The
past, and we look forward to the EUROMEDLAB Barcelona medical laboratory professions will also need to reflect on future
2019 to and become another important milestone. relationships with stakeholders outside the realm of the classical
health care professional. Specifically, concepts like “the patient-
In a very productive collaboration, the international, national oriented laboratory medicine” and “the empowered patient” will
and local organizers have done a great job to assemble an have a greatly extended meaning in the era of digitalization and
interesting scientific and professional program for you. This need to be addressed. The future will require us to set and adjust
program will give you state-of-the-art accounts not only on the standards in education and training programs in order to attract
latest analytical developments and diagnostic strategies in the the young generation of professionals with an interest in our
classical fields of Clinical Chemistry and Laboratory Medicine, multifaceted field of technical, analytical and medical expertise.
but also will provide seminal insights into future concepts and
evolutionary potentials in our field. Next to research and health I am certain that the high quality programme of EUROMEDLAB
care, education and training as well as continuous professional 2019 will reflect this and will provide you with ample opportunities
development in medical laboratory sciences will be broadly and for invigorating old contacts, making new ones and having fruitful
competently addressed during the conference. Finally, the in- discussions during the upcoming EUROMEDLAB. Therefore, on
vitro diagnostic industry will be present displaying the latest behalf of the EFLM I am looking forward to welcoming you in
technologies around the medical laboratory. A broad range of Barcelona.
international speakers, key opinion leaders and stakeholders
will bring all these developments to life discussing important Prof. Michael Neumaier
issues around science, health care and professional matters. EFLM President
Member of the Organizing Committee
4 5
DIAGNOSTICS COMMITTEES
CONGRESS ORGANISING COMMITTEE
Maurizio Ferrari, Chair
Imma Caballé, Congress President
Eric Kilpatrick, SPC Chair
Ralf Lichtinghagen
Stefano Montalbetti
WELCOME TO THE
Michael Neumaier
José M. Queraltó
COLLABORATORY
Jaime Vives
James Wesenberg
SCIENTIFIC PROGRAMME COMMITTEE
Eric Kilpatrick, Chair
WHEN BARRIERS ARE REMOVED, Sergio Bernardini
THE WHOLE SYSTEM WORKS BETTER TOGETHER Antonio Buño Soto
Imma Caballé, Congress President
Damien Gruson
Sverre Sandberg
Ian Young
of physicians say they
would value additional INTERNATIONAL SCIENTIFIC ADVISORY BOARD
77% interpretation from the Andrea Griesmacher (Austria)
lab to support diagnosis* Radivoj Jadric (Bosnia Herzegovina)
Kamen Tzatchev (Bulgaria)
Daria Pašalić (Croatia)
Spyroula Christou (Cyprus)
Richard Prusa (Czech Republic)
Liisa Kuhi (Estonia)
Anna Linko-Parvinen (Finland)
Michel Vaubourdolle (France)
Michael Vogeser (Germany)
Katherina Psarra (Greece)
Ajzner Éva (Hungary)
Ingunn Thorsteinsdottir (Iceland)
Marielle Kaplan (Israel) MEDIA PARTNERS
Giuseppe Lippi (Italy)
Dalius Vitkus (Lithuania)
Sonja Kuzmanovska (Macedonia)
Robert de Jonge (Netherlands)
Anne Lise Bjørke Monsen (Norway)
Katarzyna Fischer (Poland)
Henrique Reguengo (Portugal)
Zorica Sumarac (Serbia)
Gustáv Kováč (Slovak Republic)
Evgenija Homsak (Slovenia)
Antonio Buño Soto (Spain)
Mats Ohlson (Sweden)
Visit Abbott Diagnostics at EuroMedLab 2019 to see the impact collaboration Michel F. Rossier (Switzerland)
can have on your laboratory and the entire healthcare institution! Dogan Yucel (Turkey)
Maurice O’Kane (United Kingdom)
www.diagnostics.abbott CHOOSE TRANSFORMATION 7
ADD-00066208 * Data on file at Abbott Laboratories
executive boards
IFCC EXECUTIVE BOARD
Howard Morris, President
Maurizio Ferrari, Past President
David Kinniburgh, Secretary
Tomris Ozben, Treasurer
Rolf Hinzmann, Corporate Rep.
Adekunle B Okesina, African Federation of Clinical Chemistry (AFCC)
Abderrazek Hedhili, Arab Federation of Clinical Biology (AFCB)
Sunil Sethi, Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB)
Sverre Sandberg, European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Rosa Sierra-Amor, Latin-American Confederation of Clinical Biochemistry (COLABIOCLI)
Ann Gronowski, North American Federation of Clinical Chemistry and Laboratory Medicine (NAFCC)
EFLM EXECUTIVE BOARD
Michael Neumaier, President
Sverre Sandberg, Past President
Ana-Maria Simundic, President-Elect
Giuseppe Lippi, Secretary
Huibert Storm, Treasurer
Joao Tiago Guimaraes, Member-at-Large
Tomas Zima, Member-at-Large
SEQC EXECUTIVE BOARD
Imma Caballé, President
Francisco Bernabeu, Vice-president
José Ángel Cocho, Treasurer
Josefina Mora, Secretary
Antonio Buño, Member
Antonio Moreno, Member
Ángeles Giménez, Member
Álvaro González, Member
Dolors Balsells, Member
For information on any specific topic,
please refer to the following e-mails:
General information: info@euromedlab2019barcelona.org
Abstracts & Posters (information only): posters@euromedlab2019barcelona.org
Companies: companies@euromedlab2019barcelona.org
Registrations: registrations@euromedlab2019barcelona.org
Scientific programme & speakers: speakers@euromedlab2019barcelona.org
Hotel reservation: ekurtz@kenes.com
9
bursaries & awards
IFCC Travel Scholarships
Kenneth Weke Kenya
Sohini Sengupta India
Dwi Astuti Handayani Indonesia
Gramos Begolli Kosovo
Shah Sanjaya Kumar Nepal
Igene Itua Akhabue Nigeria
Imran Sheharbano Pakistan
Arias Randell Santos Philippines
Boudaya Mariem Tunisia
Shurko Nataliya Ukraine
EFLM Bursary Programme
Katrien Eeckhout Belgium
Elisabet González Lao Spain
Lenka Hanousková Czech Republic
Cuma Mertoglu Turkey
Marija Saric Matutinovic Serbia
Ivana Špaková Slovak Republic
Sara Tartaglione Italy
Jasmijn van Balveren The Netherlands ELEVATE YOUR PERFORMANCE.
Alen Vrtarić
Mustapha Zendjabil
Croatia
Algeria/France ADVANCE PATIENT CARE.
Your day’s work lasts a lifetime.
EFLM AWARDS At Beckman Coulter, we believe laboratories can elevate their
EFLM Scientific Award for Laboratory Medicine contributions to patient outcomes and system performance.
Sponsored by Roche It all comes down to people, processes and solutions.
EFLM Award for Excellence in Outcomes Research in Laboratory Medicine Our commitment to you is to accelerate care with a menu that
matters, bring the benefits of automation to any-sized laboratory,
Sponsored by Abbott Diagnostics
deliver greater insights through clinical informatics and unlock
hidden value through performance partnership.
EFLM Award for Excellence in Performance Specifications Research
Sponsored by Abbott Diagnostics Discover new ways we can help you elevate your performance
and advance patient care.
EFLM Cardiac Marker Award
Sponsored by HyTest
To learn more, visit us at EuroMedLab 2019, Booth 188
© 2019 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and
the Beckman Coulter product and service marks mentioned herein are trademarks or
registered trademarks of Beckman Coulter, Inc. in the United States and other countries.
For Beckman Coulter’s worldwide office locations and phone numbers, please visit
www.beckmancoulter.com/contact
10 AD-182642
SUNDAY 19 MAY
FORUM AUDITORIUM
17.00 - 20.00 Opening Ceremony
Welcome Reception
MONDAY 20 MAY
ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116 EXHIBITION HALL
09.00-10.00 PLENARY
Recent progress
on the mechanisms
of aging and
its medical
applications
10.00-10.30 BREAK
10.30-12.30 SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM SEQC
New developments Point of Care Principles and Ethical issues in New trends in
in old diseases Testing. From applications of laboratory medicine the diagnosis of
quality assurance epigenetics inborn errors of
strategies to clinical metabolism
Enhanced sample quality for
utility and patient
outcomes
12.30-13.30 EDUW 1 EDUW 2 EDUW 3 EDUW 4 EDUW 5 10.00-17.30
Abbott Beckman Coulter Mindray Roche Sysmex EXHIBITION OPEN
improved patient safety!
13.30-14.45 VIEWPOINT POSTER SESSION LUNCH
Who should lead a
medical laboratory?
14.45-15.45 EDUW 6 EDUW 7 EDUW 8 EDUW 9 EDUW 10
Preanalytical errors may delay effective diagnosis and impact treatment. At BD, Beckman Coulter Abbott Siemens Snibe Randox
we know how important it is to get it right from the beginning. We drive safe and 16.00-17.00 EDUW 11
Sysmex
EDUW 12
ThermoFisher
EDUW 13
Siemens
EDUW 14
Menarini
EDUW 15
Binding Site
accurate sample management—from collection to analysis—and throughout the 17.00-18.00 VIEWPOINT
patient journey. Meet the Thyroid
Expert
Attend the BD educational workshop TUESDAY 21 MAY
Point-of-care testing: right sample in the right place, with the right ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116 EXHIBITION HALL
09.00-10.00 PLENARY
result Cancer Pharmaco-
Room 113 Epigenetics
10.00-10.30 BREAK
Wednesday, 22nd May 10.30-12.30 SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM SEQC
Financing Advances in in-vitro A new era in Stroke and CNS EQA programs
12:30 to 13:30 Laboratory
Medicine
fertilisation communicating
diagnostics data to
biomarkers in
clinical practice
in SEQCML
Spain. Almost 30
Panelists: patients years’ experience
Dr. Ulf Martin Schilling, Consultant in emergency medicine, Linköping, Sweden evaluating the Total
Visit us
Testing Process
Dr. Andrei Tintu, Laboratory data manager, Rotterdam, The Netherlands
12.30-13.30 EDUW 16 EDUW 17 EDUW 18 EDUW 19 EDUW 20
Dr. Suzanne Bench, Associate professor, London, The United Kingdom
at booth
Beckman Coulter Abbott Mindray Roche Randox 10.00-17.30
Dr. Tracy Ellison, Director of medical affairs, BD Lifesciense, Europe EXHIBITION OPEN
13.30-14.45 VIEWPOINT VIEWPOINT POSTER SESSION LUNCH
no. 97
Young Scientist Blood-based cancer
session testing – status quo
and where to go
14.45-15.45 EDUW 21 EDUW 22 EDUW 23 EDUW 24 EDUW 25
Randox Sysmex Siemens Snibe Sebia
16.00-17.00 EDUW 26 EDUW 27 EDUW 28 EDUW 29 EDUW 30
Gentian Biorad Siemens Horiba Fujirebio
17.00-18.00 VIEWPOINT
CRISPR
bd.com
13
BD, and the BD Logo are trademarks of Becton, Dickinson and Company.©2019 BD and its subsidiaries. All rights reserved. WEU 299.1.
WEDNESDAY 22 MAY
ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116 EXHIBITION HALL
Visit us on stand 212
09.00-10.00 PLENARY
Workshop
Stem cell therapy to
cure HIV: so close,
10.00-10.30
so far
BREAK Binding
10.30-12.30 SYMPOSIUM
Preparing the
SYMPOSIUM
Laboratory
SYMPOSIUM
External Quality
SYMPOSIUM SEQC
Haemoglobin A1c in Personalised
Site
profession for Medicine training Assurance in the clinical practice immunosuppression
compliance with the in Europe - In digital era to improve clinical
new IVD Regulation
2017/746 in Europe
partnership with the
IFCC Task Force
outcomes
Monday 20th May, 2019
for Young Scientists
12.30-13.30 EDUW 31 EDUW 32 EDUW 33 EDUW 34 EDUW 35
10.00-17.30 16:00 - 17:00, Room 116 - Level 1
EXHIBITION OPEN
Siemens Becton Dickinson Ortho Clin. Diag. Roche Buhlmann
13.30-14.45 VIEWPOINT
Instrument
POSTER SESSION LUNCH
Optimise Your Time, Simplify Your Day - Optilite® delivers
verification: time
well spent?
Chair:
14.45-15.45 EDUW 37 EDUW 38 EDUW 39 EDUW 40
Diasorin Tosoh ThermoFisher ThermoFisher Dr. Juan Miguel Guerrero - Virgen del Rocío University Hospital, Spain
16.00-17.00 VIEWPOINT
Data security: Speakers:
a laboratory
perspective Mr Richard Cartwright - UK: “Optilite workflow efficiency”
Dr Ilenia Infusino - Italy: “The place of Optilite system in a decision-making
THURSDAY 23 MAY based laboratory department”
ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116
09.00-10.00 PLENARY
Noninvasive
prenatal testing
by cell-free fetal
DNA analysis:
Translating
innovations into
clinical practice
10.00-10.30 BREAK
10.30-12.30 SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM SEQC
Preanalytical phase Dyslipidemia Performance Big Data in Chronic liver
– still challenging guidelines in specification Laboratory disease: The role
for laboratory Europe and need in Laboratory Medicine of the Clinical
professionals for Standardization Medicine Laboratory
of traditional and
new cardiovascular
disease biomarkers
– addressing
cholesterol and
beyond
CLOSING CEREMONY
Learn more about Optilite and the
comprehensive assay range offered: Protein diagnostics.
www.bindingsite.com Smart solutions.
14
SCIENTIFIC PROGRAMME MONDAY, 20 MAY
SCIENTIFIC PROGRAMME
SUNDAY, 19 MAY MONDAY, 20 MAY
17:00-19:00 Forum Auditorium 9:00-10:00 Room 117
OPENING CEREMONY Plenary Lecture
Chair: S. Sandberg (Norway)
Welcome addresses
President of EuroMedLab Barcelona 2019 Imma Caballé HEALTH DATA RESEARCH UK (HDR UK):
Past President of IFCC Maurizio Ferrari OPTIONS AND OPPORTUNITIES FOR HEALTH DATA SCIENCE
President of EFLM Michael Neumaier A. Morris (UK)
A. Morris
Announcements of Awards
Honorary Membership of the Spanish Society of Laboratory Medicine (SEQCML)
Opening Lecture
Chair: M. Neumaier (Germany) Professor of Medicine Since August 2017 ANDREW MORRIS has been the inaugural
M. Serrano Director of Health Data Research UK Director of Health Data Research UK, the multi-funder UK Institute
RECENT PROGRESS ON THE MECHANISMS OF AGING AND ITS MEDICAL APPLICATIONS
Vice Principal, Data Science for health and biomedical informatics research that will capitalise
M. Serrano (Spain)
University of Edinburgh on the UK’s renowned data resources and research strengths to
Manuel Serrano obtained his PhD in 1991, from the Universidad remodeling processes during embryo development. The Serrano transform lives through health data science. He is seconded from
Autónoma de Madrid. From 1991 to 1996, Serrano worked in team was pioneer in the generation of genetically-modifed mice his position as Professor of Medicine, and Vice Principal of Data
the team of David Beach in Cold Spring Harbor Laboratory, NY. resistant to cancer and found a link between tumor suppressor Science at the University of Edinburgh, having taken up position
During this period, Serrano made his most important discovery with genes and aging. in August 2014. Prior to this Andrew was Dean of Medicine at the
the identification and characterization of the gene p16, one of the University of Dundee.
most important genes for anti-cancer protection. Serrano returned In recent years, the research interests of Manuel Serrano have
to Spain in 1997 to lead a research group, first at the National extended to metabolism and cellular reprogramming in relation Andrew was Chief Scientist at the Scottish Government Health
Center of Biotechnology (CNB), and then, from 2003 to 2017, at the to aging. The Serrano laboratory was first in demonstrating that Directorate (2012-2017) and has served and chaired numerous
Spanish National Cancer Research Center (CNIO), both in Madrid. cellular reprogramming into pluripotency is possible within an national and international grant committees and Governmental
In 2017, Serrano moved to the Institute for Research in Biomedicine organism, and this discover was considered Advance of the Year bodies.
(IRB), in Barcelona. 2013 by Nature Medicine. More recently, Serrano has reported in
Science that in vivo reprogramming is enhanced by the coexistence Andrew was awarded a CBE (Commander of the Most Excellent
Manuel Serrano is internationally recognized in the field of tumor of tissue injury thanks to the production of the interleukin IL-6. Order of the British Empire) in the 2018 New Year’s Honour’s List.
suppression. In addition to the discovery of p16, one of his main
discoveries has been the identification of cellular senescence The focus of his laboratory is now to apply their knowledge on His research interests span informatics and chronic diseases. He
as a main anti-oncogenic response. Recently, his laboratory has senescence and reprogramming to degenerative diseases such as has published over 300 original papers and has attracted over
also shown that cellular senescence participates in several tissue lung, kidney and heart fibrosis. £50million in grant funding.
19:00
Welcome Cocktail
20:00
Concert by
Orquestra Internacional Maravella
16 17SCIENTIFIC PROGRAMME MONDAY, 20 MAY SCIENTIFIC PROGRAMME MONDAY, 20 MAY
10:00-10:30
Break
10:30-12:00 Room 117 10:30-12:30 Room 114
Symposium Symposium
NEW DEVELOPMENTS IN OLD DISEASES PRINCIPLES AND APPLICATIONS OF EPIGENETICS
Chairs: E. Kilpatrick (Qatar/UK), P. Laitinen (Finland) Chairs: C.Abi Khalil (Qatar/USA), J. Oriola (Spain)
E. Kilpatrick P. Laitinen C. Abi Khalil J. Oriola
What is new in cardiac markers? Basic principles of epigenetics: DNA methylation, histone modifications and non-coding RNAs
P. Laitinen (Finland) T. Ozben (Turkey)
New diabetes treatments and the role of the laboratory Epigenetics in humans: from early development to ageing
S. Atkin (Qatar) M. Fraga (Spain)
Old and new biomarkers for kidney disease Epigenetics in diabetes and cardiovascular disease
E. Cavalier (Belgium) C.Abi Khalil (Qatar/USA)
Epigenetics in advancing drug development and personalised medicine
L. Altucci (Italy)
P. Laitinen S. Atkin E. Cavalier T. Ozben M. Fraga C.A. Khalil L. Altucci
10:30-12:30 Room 113 10:30-12:30 Room 115
Symposium Symposium
POINT OF CARE TESTING. FROM QUALITY ASSURANCE STRATEGIES ETHICAL ISSUES IN LABORATORY MEDICINE
TO CLINICAL UTILITY AND PATIENT OUTCOMES Chair: A. González Hernández (Spain), M. O’Kane (UK)
Chairs: A. Buño Soto (Spain), S. Sandberg (Norway) A. Buño Soto S. Sandberg A. González Hernández M. O’Kane
Ethical dilemmas in laboratory medicine
Quality control and analytical performance specifications for M.J. McQueen (Canada)
different clinical POCT settings. Should they be different?
S. Sandberg (Norway) Personalised genomic medicine: ethical considerations
J.J. Jonsson (Iceland)
20 years’ experience on quality assurance strategies of a large and ISO 22870 accredited POCT multiparameter network
P. Oliver (Spain) Ethical issues in direct-to-consumer testing
A. Cambon-Thomsen (France)
How the use of POCT has changed the clinical pathways and outcome for patients with infectious diseases in Africa
R. Erasmus (South Africa) Ethical issues in biomedical publication
M. O’Kane (UK)
SensUs Student Competition: Global education and innovation in POCT
E. Rutten (the Netherlands), M.V. Enrich (UK)
S. Sandberg P. Oliver R. Erasmus E. Rutten M.V. Enrich M.J. McQueen J.J. Jonsson A. Cambon-Thomsen M. O’Kane
18 19SCIENTIFIC PROGRAMME MONDAY, 20 MAY
10:30-12:30 Room 116
SEQC Symposium
NEW TRENDS IN THE DIAGNOSIS OF INBORN ERRORS OF METABOLISM
Chairs: H. Rocha (Portugal), R. Yahyaoui (Spain)
H. Rocha R. Yahyaoui
Precision medicine meets newborn screening: the path forward
P. Rinaldo (USA)
Untargeted metabolomics in the diagnosis of metabolic disorders
J. Jans (The Netherlands)
ENABLING
Inborn errors of metabolism diagnosis in Next Generation Sequencing era: opportunities and difficulties
B. Pérez (Spain) SOLUTIONS THAT BOOST
Integrative approaches for the diagnosis of
inborn errors of metabolism
H. Rocha (Portugal)
LAB PRODUCTIVITY
P. Rinaldo J. Jans B. Pérez H. Rocha
Don’t Miss Our Educational Workshop at EuroMedLab 2019
Reporting Reliable Patient Results: from Analytical Goals
13:30-14:45 to Risk Management
Poster Session
Tuesday 21 May | 16:00-17:00 | Room 113
13:30-14:30 Room 117
Viewpoint Reporting reliable analytical results from patient samples is a fundamental goal of medical laboratories.
WHO SHOULD LEAD A MEDICAL LABORATORY? Analytical performance specifications focused on biological variation will be presented in the workshop.
Chair: J. Wesenberg (Canada) J. Wesenberg
Chairman
The case for the Physician
M. Neumaier (Germany) Dr. Carmen Ricos, Spanish Society of Laboratory Medicine (SEQC-ML), Analytical Quality
Commission, Barcelona, Spain
The case for the Technologist
M. Nora Roald (Norway) Speakers
The case for the Clinical Scientist Dr. Jorge Diaz-Garzón, Hospital Universitario La Paz, Madrid, Spain
G. Wieringa (UK) Analytical performance specifications agreed in the Milan consensus. Focus on biological variation:
where the data comes from, strength and limits of this approach.
M. Neumaier M. Nora Roald G. Wieringa
Dr. Curtis Parvin, Retired (formerly Manager of Advanced Statistical Research, Bio-Rad Laboratories,
Quality Systems Division)
17:00-18:00 Room 117
Viewpoint
Presentation of a Method, based the CLSI EP23-A: Laboratory Quality Control Based on Risk
MEET THE THYROID EXPERT Management risk model, for using a quality control strategy, test method performance, and test
Chair: C. Wiley (USA) method reliability to compute the predicted probability of patient harm from erroneous test results.
D. Gruson (Belgium)
C. Wiley D. Gruson
20COMPANIES’ EDUCATIONAL WORKSHOPS MONDAY, 20 MAY
COMPANIES’ EDUCATIONAL WORKSHOPS
EDUW 6 - 14.45-15.45 ROOM 117
MONDAY, 20 MAY TAKE CONTROL WITH DXA 5000—AN INNOVATIVE AUTOMATION SOLUTION TO DELIVER
SUPERIOR WORKFLOW AND IMPROVE DELIVERY OF HEALTHCARE
EDUW 1 - 12.30-13.30 ROOM 117
Chair: W. Korte (Switzerland)
ENHANCED PATIENT CARE, REDUCED COSTS AND MEASURABLE BETTER HEALTHCARE
PERFORMANCE THROUGH IMPLEMENTATION OF INTELLIGENT LIVER FUNCTION TESTING
The world’s first—DxA 5000 and its impact on sample-TAT and healthcare delivery
(iLFT)
R. Doolman (Israel)
Chair: L. Lennartz (Germany)
Revolution, not evolution—a customer experience with DxA 5000
Speakers
M. Langan (UK)
E. Dow (UK)
J. Dillon (UK)
EDUW 7 - 14.45-15.45 ROOM 113
BIOTIN, A NEW INTERFERENCE
EDUW 2 - 12.30-13.30 ROOM 113
Chair: R. Schneider (USA) and G. Avery (UK)
REDUCING MANUAL STEPS AND IMPROVING QUALITY WITH CLINICAL INFORMATION
MANAGEMENT TOOLS TO MEET THE NEEDS OF A MODERN LABORATORY
Speaker:
Chair: S. Kookal (USA)
M.L. Piketty (France)
DxA supported by clinical informatics to reduce manual work, provide transparency and improve quality
M. Langan (UK)
EDUW 8 - 14.45-15.45 ROOM 114
LABORATORY AND CLINICAL PRACTICE GUIDES FOR IMPROVED DIAGNOSTICS AND RISK
Initiation, optimization, and application of real-time exponentially weighted moving average analysis in
OUTCOMES ASSESSMENT: LET’S TALK ABOUT HIGH-SENSITIVITY CARDIAC TROPONIN I
the clinical laboratory
Chair: A. Ortisi (Italy)
C. Crutchfield (USA)
Introduction
A. Ortisi (Italy)
EDUW 3 - 12.30-13.30 ROOM 114
PERFORMANCE OF THE BC-6800 PLUS IN SAMPLES WITH HEMATOLOGICAL ABNORMALITIES
Laboratory Medicine’s Role in Appropriate Clinical Utilization of High-Sensitivity Cardiac Troponin
Chair: G. d’Onofrio (Italy)
Assays
F. Apple (USA)
BC-6800Plus clinical evaluation: preliminary results
G. Zini (Italy)
Clinical Interpretation of High-Sensitivity Cardiac Troponin Assays in the Emergency Department
N. Mills (UK)
EDUW 4 - 12.30-13.30 ROOM 115
APPLIED USE OF DIGITAL SOLUTIONS IN LABORATORY MEDICINE
EDUW 9 - 14.45-15.45 ROOM 115
Chair: P. Quirke (UK)
CLINICAL STUDIES OF SPECIAL ASSAYS ON SNIBE MAGLUMI CLIA SYSTEM
Chiar: M. Plebani (Italy)
Challenges & Opportunities for a large automation laboratory to build the digital future
E. Gasparetto (Brazil)
Validation of Chemiluminiscent assays for hormones measurement
M. Plebani (Italy)
Implementation of a digital ecosystem to develop clinical algorithms
P. Quirke (UK)
Lipoprotein-associated phospholipase A2 level - Association with the acute coronary syndrome and the
thrombotic burden
J.M. Pego (Portugal)
EDUW 5 - 12.30-13.30 ROOM 116
THOUGHTFUL AUTOMATION - WHAT DOES THIS MEAN FOR THE CLINICAL FLOW CYTOMETRY
LABORATORY?
EDUW 10 - 14.45-15.45 ROOM 116
Chair: Dr. T. Sieber (Germany)
DEVELOPMENT AND CLINICAL EVALUATION OF AN AUTOMATED MULTI-ANALYTE BIOCHIP
ARRAY FOR RAPID STROKE DIAGNOSIS.
Speaker
Chairs: M.M. Corsi Romanelli (Italy) and J. Lamont (UK)
C. Walker (UK)
Speaker
E. Harte (Ireland)
22COMPANIES’ EDUCATIONAL WORKSHOPS MONDAY, 20 MAY
EDUW 11 - 16.00-17.00 ROOM 117
SYSMEX CARESPHERETM – THE SMART WAY OF OPTIMIZING YOUR LABORATORY IN THE
DIGITAL AGE
Chair: P. Steenhuis (Germany)
Speaker
C. Matz (Germany)
EDUW 12 - 16.00-17.00 ROOM 113
EASE-OF-USE WITHOUT COMPROMISE IN CLINICAL LC-MS/MS ALL OUR TECHNOLOGY
Chair: C. Kowalski (USA)
IN A NEW DIMENSION
Speaker
P. Van Overwalle (USA)
EDUW 13 - 16.00-17.00 ROOM 114
TRANSFORMING CARE DELIVERY WITH THE ULTIMATE CORE LABORATORY
Chair: J.-C. Clouet (France)
Introduction
J.-C. Clouet - (France)
Optimization of Lab Operations to Deliver More with Less
J. L. Bedini (Spain)
Multi-Site Performance Evaluation of Assays on the Atellica Chemistry and Immunoassay Analyzers
A. Buño Soto (Spain)
EDUW 14 - 16.00-17.00 ROOM 115
AN OLD LADY CAN STILL BE CHARMING: HOW IFA IS EVOLVING TOWARDS AUTOMATION
Chair: N. Bizzaro (Italy)
Introduction
N. Bizzaro (Italy)
IFA attempts of standardization from the manufacturing point of view and from a routine daily lab work.
Automation as a step forward standardization.
P. Carulla i Sanmartí (Spain)
Zenit PRO: analytical evaluation of the system. How the use of a completely automated system can
streamline the complete IFA protocol.
M. Fabris (Italy)
EDUW 15 - 16.00-17.00 ROOM 116
OPTIMISE YOUR TIME, SIMPLIFY YOUR DAY – OPTILITE DELIVERS
Chair: J. M. Guerrero (Spain)
Optilite workflow efficiency
Delivers the difference
R. Cartwright (UK)
The place of Optilite system in a decision making based laboratory department
I. Infusino (Italy)
24 FOR OUTSIDE THE US AND CANADA/OR CANADA ONLY PRODUCT AVAILABILITY SUBJECT TO REQUIRED REGULATORY APPROVALSSCIENTIFIC PROGRAMME TUESDAY, 21 MAY
TUESDAY, 21 MAY
Aim higher! 9:00-10:00 Room 117
Plenary Lecture
Chair: A.M. Simundic (Croatia)
Add specialty to your routine. CANCER PHARMACO-EPIGENETICS
M. Esteller (Spain)
M.Esteller
Manel Esteller (Sant Boi de Llobregat, Barcelona, Catalonia, Spain, Author of 485 original publications in peer-reviewed scientific
1968) graduated in Medicine from the Universidad de Barcelona journals, sixteen of them categorized as “Highly Cited Paper” by
in 1992, where he also obtained his Ph.D. degree specialising in Thomson Reuters. Dr Esteller has a Total Impact Factor of 4,488.212
molecular genetics of endometrial carcinoma, in 1996. He was and a Total Number of Citations of 56,846, having an h-Index of 116.
an Invited Researcher at the School of Biological and Medical He is also a Member of numerous international scientific societies,
Sciences at the University of St. Andrews, (Scotland, UK) during Editorial Boards and reviewer for many journals and funding
which time his research interests focused on the molecular genetics agencies. Dr Esteller is also Associate Editor for Cancer Research,
of inherited breast cancer. From 1997 to 2001, Esteller was a The Lancet Oncology, Carcinogenesis, Genome Research and The
Postdoctoral Fellow and a Research Associate at the Johns Hopkins Journal of The National Cancer Institute. He is also Editor-in-Chief
University and School of Medicine, (Baltimore, USA) where he of Epigenetics.
studied DNA methylation and human cancer. His work was decisive
in establishing promoter hypermethylation of tumour suppressor His work has received, among other, the Carcinogenesis Award
genes as a common hallmark of all human tumours. From October (2005), Beckman-Coulter Award (2006), Fondazione Piemontese
2001 to September 2008 Manel Esteller was the Leader of the CNIO per la Ricerca sul Cancro (FPRC) Award (2006), Swiss Bridge
Cancer Epigenetics Laboratory, where his principal area of research Award (2006), Innovation Award from the Commonwealth of
were the alterations in DNA methylation, histone modifications and Massachussets (2007), Human Frontier Science Program Award
chromatin in human cancer. Since October 2008, Dr Esteller is the (2007), DEbiopharm-EPFL Award (2009), Dr. Josef Steiner Cancer
Director of the Cancer Epigenetics and Biology Program (PEBC) Research Award (2009), Lilly Foundation Preclinical Biomedical
of the Bellvitge Institute for Biomedical Research (IDIBELL) in Research Award (2009), World Health Summit Award (2010), the
Barcelona, Chairman of Genetics in the School of Medicine of the European Research Council Advanced Grant (2011), “Rey Jaime
Join us for coffee University of Barcelona, and an ICREA Research Professor. His I” Research Award (2013), Severo Ochoa Award in Biomedicine
and see our current research is devoted to the establishment of the epigenome (2014), National Award in Oncology (2014), “Dr Josep Trueta
automated CLEIA maps of normal and transformed cells, the study of the interactions Medal” Generalitat de Catalunya, Catalan Goverment (2015),
analyzers between epigenetic modifications and non-coding RNAs, and the National Research Award of the Catalan Goverment (2015), Gold
BOOTH 126 development of new epigenetic drugs for cancer therapy. Medal, Parlament of Catalonia (2016), International Award of
Catalonia (2016), Falcó Carlemany Award (2017) and Innovation in
Healthcare Oncology Award (2018)
JOIN OUR EDUCATIONAL SYMPOSIUM ON MAY 21ST WITH TWO EMINENT SPEAKERS:
© Fujirebio Europe, February 2019, FRE-161
Sjoerd van den Berg (Erasmus MC, Rotterdam) and Daniel Alcolea (Hospital de la Santa Creu i Sant Pau, Barcelona)
Reviewing a new Anti-Mullerian hormone assay and the first complete panel for fully automated biomarker
testing in Alzheimer’s disease
Educational Workshop #30 (Room 116 – Level 1) on Tuesday, May 21st from 16.00 to 17.00
More information at: www.fujirebio.com/specialty
27SCIENTIFIC PROGRAMME TUESDAY, 21 MAY SCIENTIFIC PROGRAMME TUESDAY, 21 MAY
10:30-12:30 Room 117 10:30-12:30 Room 114
Symposium Symposium
FINANCING LABORATORY MEDICINE A NEW ERA IN COMMUNICATING DIAGNOSTICS DATA TO PATIENTS
Chairs: I. Caballé (Spain), D. Gruson (Belgium) Chairs: K. Adeli (Canada), J.R. Bauzá (Spain)
I. Caballé D. Gruson K. Adeli J.R. Bauzá
Integrating laboratory medicine into national and hospital health budgets Classification and benchmarking apps for patients and professionals
T. Marti (Spain) S. Jovicic (Serbia)
Transformation of the health technology sector: real world data and patient driven innovation Personalised communication of results to patients
C. Velasco Muñoz (Spain) I. Watson (UK)
Broadening access for innovative diagnostic solutions Electronic apps and medical diagnostics data management
N. Farkas (Switzerland) K. Adeli (Canada)
Round table with speakers Online resources for patients and healthcare professionals
T. Pillay (South Africa)
T. Marti C. Velasco Muñoz N. Farkas S. Jovicic I. Watson K. Adeli T. Pillay
10:30-12:30 Room 113
Symposium 10:30-12:30 Room 115
ADVANCES IN IN-VITRO FERTILISATION Symposium
Chairs: J. Olofsson (Sweden), C. Sánchez Pozo (Spain) STROKE AND CNS BIOMARKERS IN CLINICAL PRACTICE
Chairs: A. Haliassos (Greece), J. Montaner (Spain)
Reproductive medicine in 2019 – the 7 key Questions: J. Olofsson C. Sánchez Pozo A. Haliassos J. Montaner
Who, What, Why, When, Where, How, How Much? Stroke Biomarkers Discovery
N. Polyzos (Spain) J. Montaner (Spain)
Fertility preservation a look into the future Guiding stroke therapy with the use of blood biomarkers
A. Arav (Israel) A. Bustamante (Spain)
Advances in ovarian stimulation regimens and monitoring during in-vitro fertilisation Are stroke biomarkers ready for research and clinical use? Focus on the pre-analytical, analytical and post-analytical variability
J. Olofsson (Sweden) K. Makris (Greece)
The role of the laboratory in IVF success CSF Xanthochromia in the investigation of suspected subarachnoid haemorrhage
J. Hreinsson (Sweden) G. Burrows (UK)
N. Polyzos A. Arav J. Olofsson J. Hreinsson J. Montaner A. Bustamante K. Makris G. Burrows
28 29SCIENTIFIC PROGRAMME TUESDAY, 21 MAY SCIENTIFIC PROGRAMME TUESDAY, 21 MAY
10:30-12:30 Room 116 13:30-14:45 Room 113
SEQC Symposium Viewpoint
EQA PROGRAMS IN SEQCML SPAIN. ALMOST 30 YEARS’ EXPERIENCE BLOOD-BASED CANCER TESTING – STATUS QUO AND WHERE TO GO
EVALUATING THE TOTAL TESTING PROCESS Chair: V. Haselmann (Germany), G. Shannan (Syria)
F. Ramón Bauzá C. Ricós Aguilá V. Haselmann G. Shannan
Chairs: F. Ramón Bauzá (Spain), C. Ricós Aguilá (Spain)
Liquid biopsy from a clinical point of view
Quality specifications in EQA of Total Testing Process. Is there an international agreement? M. González Cao (Spain)
P. Fernández-Calle (Spain)
Advances of circulating tumor DNA in diagnostics and early detection of cancer
Achievement of quality specifications based on biological variation. Is there a positive evolution? D. van de Broek (the Netherlands)
C. Ricós Aguilá (Spain)
The molecular tumor board as imperative for integrating blood-based cancer testing into clinical decision making
Evolution of state-of-the-art over almost 30 years: imprecision and bias detection trough EQA. Interaction among EQA organizers, A. Ferreira-Gonzalez (USA)
IVD and participant laboratories
C. Perich Alsina (Spain)
Evolution of quality indicators over more than 20 years.
Looking back and forward
M. Ibarz Escuer (Spain)
M. González-Cao D. van de Broek A. Ferreira-Gonzqalez
P. Fernández-Calle C. Ricós Aguilá C. Perich Alsina M. Ibarz Escuer
13:30-14:15 Room 117 17:00-17:45 Room 117
Viewpoint Viewpoint
YOUNG SCIENTIST SESSION CRISPR
Chairs: J.M. Bauçá (Spain), J.R. Bauzá (Spain) Chair: T. Zima (Czech Republic)
Worldwide YS groups/organizations. Different boarding models L.M. Bauçá J.R. Bauzá Speaker T. Zima L. Montoliu
C. Imperiali (Spain) L. Montoliu (Spain)
Publishing key points, how can I succeed publishing in top journals?
A.M. Simundic (Croatia)
Young Scientist: Career prospect, research, and networking
R. Shrestha (Japan)
C. Imperiali A.M. Simundic R. Shrestha
30 31COMPANIES’ EDUCATIONAL WORKSHOPS TUESDAY, 21 MAY
TUESDAY, 21 MAY
EDUW 16 - 12.30-13.30 ROOM 117
Come and visit us EARLY SEPSIS INDICATOR - A NOVEL SEPSIS BIOMARKER: CLINICAL PERFORMANCE AND
at our booth #271 CASE STUDIES
Chair: M. Plebani (Italy)
MDW: A New Early Sepsis Indicator—Performance in clinical trials and case studies
K. Bicking (USA)
First results on MDW performance on patients in ED and ICU in University Hospital Germans Trías i
Pujol
B. Catalán Eraso (Spain)
EDUW 17 - 12.30-13.30 ROOM 113
USING LABORATORY TESTS TO TRANSFORM POPULATION HEALTH MANAGEMENT
Chairs: R. Schneider (USA), C. Galli (Italy)
Risk stratification of general practice patients using hs Troponin I
A. Shah (UK)
Health economic evaluation of using high sensitivity troponin I for cardiovascular risk prediction in the
BiomarCaRE cohort
N. Makarova (Germany)
Wish to find the answer Tackling Hepatitis C Elimination - are we flying blind?
J.V. Lazarus (Spain)
for laboratory challenges?
EDUW 18 - 12.30-13.30 ROOM 114
Do not miss our Workshop! NEW BIOMARKERS IN SEPSIS
Chairs: M. M. Corsi Romanelli (Italy), J. He (China)
Tuesday, May 21st, 2019 – 16:00 – 17:00
Room 115, level 1 New generation biomarkers of infection
E. Galliera (Italy)
We are pleased to invite you
to our 3-session workshop about: EDUW 19 - 12.30-13.30 ROOM 115
EVIDENCE-BASED VALUE CARE DELIVERY
Chair: A. L. Justel (Spain)
1. The HELO* Solution - supporting customer validation and ISO 15189 accreditation in the UK.
Ms. Mandy CAMPBELL - HORIBA Medical, UK Reinventing Healthcare
L. Engelen (Netherlands)
2. Performance of Yumizen® H2500/H1500 versus main high range hematology manufacturers.
Pr. Sukesh C. NAIR - Christian Medical College, Vellore, India Value Based Innovation in Heart Failure patient management
A. L. Justel (Spain)
3. Interest of Yumizen® H1500/H2500 technology in patients with Diff abnormalities due to malignant
blood disease or after chemotherapy treatment.
Dr. Francoise DURRIEU - Institut Bergonié, Bordeaux, France EDUW 20 - 12.30-13.30 ROOM 116
SECRETED PHOSPHOLIPASES A2 AND CARDIOVASCULAR RISK
Chairs: M.M. Corsi Romanelli (Italy), J. Lamont (UK)
We look forward to welcoming you!
*HORIBA Evolutive Laboratory Organisation Speaker
S. Hammond (UK)
33COMPANIES’ EDUCATIONAL WORKSHOPS TUESDAY, 21 MAY COMPANIES’ EDUCATIONAL WORKSHOPS TUESDAY, 21 MAY
EDUW 21 - 14.45-15.45 ROOM 117 EDUW 25 - 14.45-15.45 ROOM 116
NOVEL MULTIPLEX MOLECULAR DIAGNOSTICS: A CROSS-PLATFORM COMPARISON WHAT’S NEW IN MULTIPLE MYELOMA DIAGNOSIS: FROM SEBIA FLC CLINICAL VALIDATION
Chairs: M.M. Corsi Romanelli (Italy) , J. Lamont (UK) TO SOFTWARE ASSISTED INTERPRETATIONS OF SERUM PROTEIN ELECTROPHORESIS
PROFILES
Speaker Chair: H. Jacobs (Netherlands)
M. Crockard (UK)
The diagnosis of protein disorders in a decision making-based laboratory department
A. Dolci (Italy)
EDUW 22 - 14.45-15.45 ROOM 113
GAINING INSIGHT WITH REVEALING TECHNOLOGY: FROM INFECTION TO INFLAMMATION Clinical validation of the new sebia FLC on a population of Multiple Myeloma patients
AND IMMUNE RESPONSE T. Dejoie (France)
Chair: A. Wevelsiep (Germany)
Infections in urinalysis – the need for rapid and differentiated results EDUW 26 - 16.00-17.00 ROOM 117
C. Alonso-Tarrés (Spain) PLASMA CALPROTECTIN: A PROMISING EARLY BIOMARKER FOR THE DIAGNOSIS OF
BACTERIAL INFECTIONS AND SEPSIS
Visualising immune response using XN technology Chair: A. Havelka (Norway)
R. Jammal (Lebanon)
Diagnosis of severe infections and sepsis: Challenges with current biomarkers
J. Rello (Spain)
EDUW 23 - 14.45-15.45 ROOM 114
EVOLVING ROLE OF BIOMARKERS IN PRENATAL CARE Calprotectin as a risk marker in emergency department patients with acute dyspnea
Chair: E. Rojas-Kenney (USA) T. Ruge (Sweden)
Speakers
E. Gratacós (Spain) EDUW 27 - 16.00-17.00 ROOM 113
M. L. Hortas (Spain) REPORTING RELIABLE PATIENT RESULTS: FROM ANALYTICAL GOALS TO RISK MANAGEMENT
Chair: C. Ricós (Spain)
EDUW 24 - 14.45-15.45 ROOM 115 Analytical performance specifications agreed in the Milan consensus. Focus on Biological variation,
CLINICAL APPLICATION OF SPECIAL LIVER DISEASES MARKERS AND DIABETES MARKERS where the data come from, strength and limits of this approach.
Chair: W. Tamimi (Saudi Arabia) J. Díaz-Garzón (Spain)
Clinical validation of Hyaluronic Acid in patients with liver diseases Presentation of a Method, based the CLSI EP23-A: Laboratory Quality Control Based on Risk
W. Tamimi (Saudi Arabia) Management risk model, for using a quality control strategy, test method performance, and test method
reliability to compute the predicted probability of patient harm from erroneous test results.
New trends in clinical diagnostic C. Parvin (USA)
S. Cuesta de Juan (Spain)
EDUW 28 - 16.00-17.00 ROOM 114
FLC KAPPA AND LAMBDA TESTING IN CSF TO SUPPORT DIAGNOSIS OF NEUROLOGICAL
DISEASES
Chair: C. Prümper (Germany)
Introduction
C. Prümper (Germany)
Free light chain kappa index to identify patients with oligoclonal bands
A. Dressel (Germany)
Cerebrospinal fluid free light chains as a diagnostic biomarker in neuroborreliosis
H. Hegen (Austria)
34 35COMPANIES’ EDUCATIONAL WORKSHOPS TUESDAY, 21 MAY
EDUW 29 - 16.00-17.00 ROOM 115
SCIENTIFIC, OPERATIONAL AND REGULATORY CHALLENGES FOR THE HIGH COMPLEXITY/
HIGH THROUGHPUT HEMATOLOGY LABORATORIES
Chair: M. Cloës (USA)
The HELO solution (HORIBA Evolutive Laboratory Organization) - supporting customer validation and
ISO 15189 accreditation in the UK
M. Campbell (UK)
Performance of HORIBA Medical Yumizen® H2500/H1500 versus main high range hematology
manufacturers
S. C. Nair (India)
Interest of HORIBA Medical Yumizen® H1500/H2500 technology in patients with Diff abnormalities due
to malignant blood disease or after chemotherapy treatment
F. Durrieu (France)
EDUW 30 - 16.00-17.00 ROOM 116
ADD SPECIALTY TO YOUR ROUTINE: REVIEWING A NEW ANTI-MULLERIAN HORMONE
ASSAY AND THE FIRST COMPLETE PANEL FOR FULLY AUTOMATED BIOMARKER TESTING IN
ALZHEIMER’S DISEASE
Chair: R. Maertens (Belgium)
Detailed insight into the low range performance of Lumipulse G AMH
S. van den Berg (Netherlands)
A complete CSF biomarker profile for Alzheimer’s disease in the era of automation and standardization
D. Alcolea (Spain)
36SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY
WEDNESDAY, 22 MAY
10:30-12:30 Room 115
9:00-10:00 Room 117 Symposium
Plenary Lecture HAEMOGLOBIN A1c IN CLINICAL PRACTICE
Chair: D. Kinniburgh (Canada) Chairs: M.L. Granada (Spain), G. John (UK)
M.L. Granada G. John
STEM CELL THERAPY TO CURE HIV: SO CLOSE, SO FAR Diagnosis of Diabetes using HbA1c: More than just the glucose concentration to consider
J. Martinez-Picado (Spain) E. English (UK)
External Quality Assessment of HbA1c; lessons learnt and future prospects for quality targets
J. Martinez-Picado
C. Weykamp (Netherlands)
Should HbA1c POCT be accepted for diagnosis of Type 2 Diabetes
E. Lenters-Westra (Netherlands)
Javier Martinez-Picado is an ICREA Research Professor at the understanding how HIV causes disease and the research of cure When and how is a person with Type 2 Diabetes in Remission
AIDS Research Institute IrsiCaixa in Barcelona, where he leads the strategies. He co-leads the IciStem consortium to investigate the
C. Le Roux (UK)
Retrovirology and Clinical Studies group. He is also an associate potential for HIV cure by allogeneic stem cell transplantation.
professor at the University of Vic (UVic-UCC). He received his PhD He serves on several governmental, academic and industry advisory
in Microbiology from the University of Barcelona, where he also boards. He has published more than 170 papers on HIV treatment
lectured as an associate professor. strategies and HIV pathogenesis in international journals.
He later engaged in HIV/AIDS research at the Harvard Medical
School (Boston). His current scientific interests focus on
E. English C. Weykamp E. Lenters-Westra C. Le Roux
10:30-12:30 Room 113
Symposium
LABORATORY MEDICINE TRAINING IN EUROPE
In partnership with the IFCC Task Force for Young Scientists
Chairs: P. Dabla (India), E. Homsak (Slovenia)
P. Dabla E. Homsak
Practical knowledge and skills management- why to participate?
E. Homsak (Slovenia)
Research opportunities & skills - gateway for career enhancement
P. Dabla (India)
Current status of training in Labs - gaps and needs
L. Parnas (USA)
European Young Scientists: Training and Career
G. Boursier (France)
E. Homsak P. Dabla L. Parnas G. Boursier
38 39SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY
10:30-12:30 Room 114 10:30-12:30 Room 116
Symposium SEQC Symposium
EXTERNAL QUALITY ASSURANCE IN THE DIGITAL ERA PERSONALISED IMMUNOSUPPRESSION TO IMPROVE CLINICAL OUTCOMES
Chairs: P. Meijer (Netherlands) A. Thomas (UK) Chairs: M. Brunet (Spain), T. van Gelder (Netherlands)
P. Meijer A. Thomas M. Brunet T. van Gelder
The digital era: a paradigm shift in external quality assurance Monitoring tacrolimus intracellular concentrations:
A. Thomas (UK) would it help better predicting graft clinical outcome?
F. Lemaitre (France)
Challenges in EQA and POCT
A. Stavelin (Norway) Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs
T. van Gelder (Netherlands)
Present and future possibilities of virtual EQA
I. Juhos (Hungary) Improving clinical outcome using TDM in paediatric liver transplantation
E. Frauca (Spain)
Can patient medians replace or give additional value to the traditional external quality assessment schemes?
L. Thienpont (Belgium) The role of biomarkers in transplantation
M. Brunet (Spain)
A. Thomas A. Stavelin I. Juhos L. Thienpont F. Lemaitre T. van Gelder E. Frauca M. Brunet
10:30-12:30 Room 117 13:30-14:15 Room 117
Symposium Viewpoint
PREPARING THE PROFESSION FOR COMPLIANCE WITH Chairs: A. Gronowski (USA), R. Sierra Amor (Mexico)
THE NEW IVD REGULATION 2017/746 IN EUROPE INSTRUMENT VERIFICATION: TIME WELL SPENT? A. Gronowski R. Sierra Amor
Chairs: C. Cobbaert (Netherlands), J. Vives (Spain)
C. Cobbaert J. Vives
Yes
The new IVD Regulation 2017/746 and consequences for Laboratory Medicine C. Sturgeon (UK)
C. Cobbaert (Netherlands)
No
A Comprehensive Framework for Test Evaluation under the new IVD regulation E. Kilpatrick (Qatar/UK)
R. Horvath (Australia)
What type of Clinical Evidence and Clinical Performance Study designs are required under the new IVDR era? C. Sturgeon E. Kilpatrick
P. Bossuyt (Netherlands)
Defining Clinical Performance Specifications in the new IVD era
S. Lord (Australia) 16:00-17:00 Room 117
Viewpoint
DATA SECURITY: A LABORATORY PERSPECTIVE
Chair: J.T. Guimaraes (Portugal)
Speaker
J. Rossler (Belgium)
C. Cobbaert R. Horvath P. Bossuyt S. Lord
J.T. Guimaraes J. Rossler
40 41STAND 236
COMPANIES’ EDUCATIONAL WORKSHOPS WEDNESDAY, 22 MAY
WEDNESDAY, 22 MAY
EDUW 31 - 12.30-13.30 ROOM 117
EFFECTIVE PATIENT MANAGEMENT THROUGH EARLY DIAGNOSIS AND TREATMENT
The path to a more effective lab starts here: Chair: D. Brivio (Italy)
Automating A/C ratio in systematic urinalysis for early detection of kidney disease
F. Cava Valenciano (Spain)
Leveraging patient-side testing in emergency medical interventions
E. Corral Torres (Spain)
LEARN EXPLORE EMBRACE PREVENT
How biomarker guided Exceptional technology. Digital Chemistry and with Ortho Care™, an
EDUW 32 - 12.30-13.30 ROOM 113
therapy can reduce Excellent quality. deliver enhanced patient exclusive holistic support
acute kidney injury Extraordinary care! care, more effective data model that anticipates your
POINT-OF-CARE TESTING: RIGHT SAMPLE IN THE RIGHT PLACE, WITH THE RIGHT RESULT
and dialysis rates! and improved throughput! laboratory evolving needs! Chair: A. Ahuja (USA)
Panelists:
U. M. Schilling (Sweden)
A. Tintu (Netherlands)
S. Bench (UK)
EduWS 33 Wednesday 22 May. Room 114 12h30–13h30 T. Ellison (UK)
EDUW 33 - 12.30-13.30 ROOM 114
The clinical use and performance of high-sensitivity (hs) Cardiac Troponin assays THE CLINICAL USE AND PERFORMANCE OF HIGH-SENSITIVITY (HS) CARDIAC TROPONIN
with the ESC 0-1 hour algorithm: overcoming challenges in implementation. ASSAYS WITH THE ESC 0-1 HOUR ALGORITHM: OVERCOMING CHALLENGES IN
IMPLEMENTATION
Chair: F. Apple (USA)
Chairman/Scientific coordinator
Speakers
Fred S Apple, PhD F. Apple (USA)
J. Boeddinghaus (Switzerland)
Co-Director Clinical & Forensic Toxicology
Laboratory, Hennepin Healthcare/Hennepin
County Medical Center; Principal Investigator, EDUW 34 - 12.30-13.30 ROOM 115
Cardiac Biomarkers Trials Laboratory (CBTL), CAUSES AND IMPACT OF LAB RESULT MISINTERPRETATION
Hennepin Healthcare Research Institute Chair: L. Giovanella (Switzerland)
(HHRI); Professor, Laboratory Medicine &
Pathology, University of Minnesota. Immunoassay Interferences: facts, insights and a pragmatic approach
N. Tran (USA)
Speaker
The clinicians’ approach to immunoassay results
Jasper Boeddinghaus, MD L. Giovanella (Switzerland)
Physician at the Department of Cardiology
University Hospital Basel.
EUROMEDLAB BARCELONA. 19-23 May 2019
More about ORTHO at www.orthoclinicaldiagnostics.com
PR-04893COMPANIES’ EDUCATIONAL WORKSHOPS WEDNESDAY, 22 MAY COMPANIES’ EDUCATIONAL WORKSHOPS WEDNESDAY, 22 MAY
EDUW 35 - 12.30-13.30 ROOM 116 EDUW 40 - 14.45-15.45 ROOM 116
IBD BIOMARKER FECAL CALPROTECTIN - FROM NICHE TO FULL AUTOMATION – STATE OF PROCALCITONIN TESTING: DIAGNOSTIC PERFORMANCE LINKED TO SAFE MANAGEMENT
THE ART MANAGEMENT FOR WORKFLOW OPTIMIZATION OF BACTERIAL INFECTIONS
Chair: A. Havelka (Norway) Chair: J. Ordóñez (Spain)
Clinical Aspects of Fecal Calprotectin in IBD PCT 2019 - The Clinical Perspective
P. F. Van Rheenen (Netherlands) M. Bassetti (Italy)
Laboratory Workflow Optimization in the Field of Fecal Calprotectin Testing PCT 2019 – The Perspective of the Laboratory
L. Germagnoli (Italy) M. Plebani (Italy)
Fecal Calprotectin in Modern Clinical Chemistry
L. Bestmann (Switzerland)
Full Automation – The Future Laboratory
M. Redondo (Switzerland)
EDUW 37 - 14.45-15.45 ROOM 113
NEW APPROACHES TO LATENT TB DETECTION AND TREATMENT
Chair: D. Goletti (Italy)
Latent Tuberculosis and TB control today
J. P. Zellweger (Switzerland)
LIAISON QuantiFERON-TB Gold Plus: automation in LTBI testing
C. Labdon (UK)
EDUW 38 - 14.45-15.45 ROOM 114
NEW INSIGHT IN THE DIAGNOSIS AND MONITORING OF DIABETIC PATIENTS
Chair: A. León (Spain)
Diabetes monitoring: new international guidelines
A. Lapolla (Italy)
Biomarkers: improvement in analytical and interpretative features
M. Zaninotto (Italy)
EDUW 39 - 14.45-15.45 ROOM 115
ENSURING A HEALTHIER TOMORROW: NOVEL TOOLS FOR CLINICAL RESEARCH
Chair: D. Bhattacharyya (USA)
Tuborflow online sample extraction and multi-channel LC-MS/MS as versatile tools for clinical research
laboratories
M. Brambilla (Italy)
Identification of Hemoglobinopathies and Thalassemias - A prospective study of up to 5.000 newborn
sample for clinical research
T. Wiesinger (Austria)
44 45SCIENTIFIC PROGRAMME THURSDAY, 23 MAY
THURSDAY, 23 MAY
9:00-10:00 Room 117
DEDICATED TO IMPROVING HEALTH WORLDWIDE Plenary Lecture
Chair: M. Ferrari (Italy)
NONINVASIVE PRENATAL TESTING BY CELL-FREE FETAL DNA ANALYSIS:
CLINICAL CHEMISTRY ANALYSERS TRANSLATING INNOVATIONS INTO CLINICAL PRACTICE
The RX series clinical chemistry analysers offer high quality semi-automated and R. Chiu (Hong Kong)
fully automated testing. Renowned for quality and reliability, the RX series excels
by combining robust hardware, intuitive software and a world leading test menu
R. Chiu
featuring routine and novel high performing reagents.
THIRD PARTY REAGENTS
An extensive range of 114 third party biochemistry diagnostic assays, facilitating routine Rossa Chiu is the Choh-Ming Li Professor of Chemical Pathology She has continued to develop expanded applications of non-invasive
and niche testing. Randox Reagents are internationally recognised as being of the highest and Associate Dean (Development) at the Faculty of Medicine, The prenatal diagnostics, including approaches to assess fetal single
quality, producing accurate and precise results. Applications are available detailing Chinese University of Hong Kong. She serves as the Honorary gene diseases, to detect fetal de novo mutations, to decipher the
Chief of Service of the Department of Chemical Pathology, Prince fetal genome and to assess tissue-of-origin of pathologies. To date,
instrument-specific settings for a wide range of biochemistry analysers.
of Wales Hospital, Hong Kong. Prof Chiu studied medicine at the Prof Chiu has published over 150 peer-reviewed research articles
University of Queensland, Australia and later pursued her Doctor and has over 250 granted patents or patent applications. Prof Chiu
IMMUNOASSAY ANALYSERS of Philosophy studies at The Chinese University of Hong Kong. has received a number of awards for her research, including the
She is a Fellow of the Royal College of Pathologists of Australasia 2011 International Federation of Clinical Chemistry and Laboratory
The Evidence Series immunoassay analysers utilise innovative biochip array technology
in both Genetic Pathology and Chemical Pathology. Prof Chiu’s Medicine (IFCC) Young Investigator Award, the 2012 China
for a rapid and accurate simultaneous qualitative detection of a wide range of analytes
research interests lie in the analysis of circulating nucleic acids Women in Science Fellowship, the 2013 American Association of
from a single patient sample. Panels are available for Clinical, Toxicology, Molecular,
found in human plasma. She has made significant contributions to Clinical Chemistry Outstanding Scientific Contributions for a Young
and Research testing. the development of non-invasive prenatal diagnosis which led to the Investigator and the 2016 Croucher Senior Medical Research
worldwide introduction of non-invasive plasma DNA tests for Down Fellowship. She has been elected to serve as Secretary to the Board
BIOSCIENCES syndrome screening. of Directors of the International Society of Prenatal Diagnosis. She
was the President of the Hong Kong Society of Clinical Chemistry
Randox Biosciences, part of Randox Laboratories is dedicated to advancing
between 2004 to 2005.
scientific discovery, drug development and diagnostics. Spanning four key divisions;
Bio-Reagents, BioPharma, Academic Research and Clinical Laboratory; Randox
Biosciences offers complete tailored solutions for clinical and research use.
QUALITY CONTROL
True third party controls, external quality assessment, interlaboratory data
management, calibration verification and a range of IQC and EQA for molecular
infectious disease testing are all available with our range of complete QC solutions.
TOXICOLOGY
With the world’s most extensive toxicology test menu, Randox Toxicology provide
innovative solutions for fast and accurate drugs of abuse detection. Our pioneering
Biochip Array Technology enables rapid detection of drugs and metabolites in various
biological specimens from a single sample.
Visit us at: Booth 184
Visit randoxonlinestore.com #ImprovingHealth
to buy directly from Randox today randox.com/improving-health
Product availability may vary from country to country. Some product may be for Research use Only.
For more information on product application and availability, please contact your local Randox Representative
47You can also read
